- The creator of smart rings Oura received $75 mln investment - The investor is medical device maker Dexcom - The deal will help the companies share data and more - Finnish Oura's valuation for the deal will be around $5+ billion - Two years ago, the startup was valued at $2.6 billion - The companies want to make it easier for their products to interact - Dexcom's glucose level data will become part of Oura - Dexcom had earlier received US regulatory approval for Stelo - It's about a $99 continuous tracker that doesn't require a prescription - One in 5 Oura users have used such trackers - Oura's revenues could be as high as $500 million by the end of 2024 - Oura has sold 2.5+ million smart rings to date